108 related articles for article (PubMed ID: 2527301)
41. Formation of an inactive cytochrome P-450 Fe(II)-metabolite complex after administration of troleandomycin in humans.
Pessayre D; Larrey D; Vitaux J; Breil P; Belghiti J; Benhamou JP
Biochem Pharmacol; 1982 May; 31(9):1699-704. PubMed ID: 6980648
[TBL] [Abstract][Full Text] [Related]
42. In vivo effects of erythromycin, oleandomycin and erythralosamine derivatives on hepatic cytochrome P-450.
Delaforge M; Sartori E
Biochem Pharmacol; 1990 Jul; 40(2):223-8. PubMed ID: 2375764
[TBL] [Abstract][Full Text] [Related]
43. Dual effects of macrolide antibiotics on rat liver cytochrome P-450. Induction and formation of metabolite-complexes: a structure-activity relationship.
Delaforge M; Jaouen M; Mansuy D
Biochem Pharmacol; 1983 Aug; 32(15):2309-18. PubMed ID: 6603844
[TBL] [Abstract][Full Text] [Related]
44. Pharmacokinetic interactions between erythromycin, clarithromycin, roxithromycin and phenytoin in the rat.
al-Humayyd MS
Chemotherapy; 1997; 43(2):77-85. PubMed ID: 9084915
[TBL] [Abstract][Full Text] [Related]
45. Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450. Studies in rats and patients.
Watkins PB; Murray SA; Winkelman LG; Heuman DM; Wrighton SA; Guzelian PS
J Clin Invest; 1989 Feb; 83(2):688-97. PubMed ID: 2913056
[TBL] [Abstract][Full Text] [Related]
46. Induction of cytochrome P-450 in rat liver by the antibiotic troleandomycin: partial purificaton and properties of cytochrome P-450-troleandomycin metabolite complexes.
Mansuy D; Delaforge M; LeProvost E; Flinois JP; Columelli S; Beaune P
Biochem Biophys Res Commun; 1981 Dec; 103(4):1201-8. PubMed ID: 6977361
[No Abstract] [Full Text] [Related]
47. Triacetyloleandomycin as inducer of cytochrome P-450 LM3c from rabbit liver microsomes.
Bonfils C; Dalet-Beluche I; Maurel P
Biochem Pharmacol; 1985 Jul; 34(14):2445-50. PubMed ID: 3874626
[TBL] [Abstract][Full Text] [Related]
48. Induction protocols for cytochromes P450IIIA in vivo and in primary cultures of animal and human hepatocytes.
Daujat M; Pichard L; Fabre I; Pineau T; Fabre G; Bonfils C; Maurel P
Methods Enzymol; 1991; 206():345-53. PubMed ID: 1784221
[No Abstract] [Full Text] [Related]
49. Inactivation of rat hepatic cytochrome P-450 by spironolactone.
Decker C; Sugiyama K; Underwood M; Correia MA
Biochem Biophys Res Commun; 1986 May; 136(3):1162-9. PubMed ID: 3487316
[TBL] [Abstract][Full Text] [Related]
50. Pharmacokinetics of clarithromycin in rats with acute renal failure induced by uranyl nitrate.
Lee AK; Lee JH; Kwon JW; Kim WB; Kim SG; Kim SH; Lee MG
Biopharm Drug Dispos; 2004 Sep; 25(6):273-82. PubMed ID: 15334627
[TBL] [Abstract][Full Text] [Related]
51. Metabolism of dihydroergotamine by a cytochrome P-450 similar to that involved in the metabolism of macrolide antibiotics.
Delaforge M; Rivière R; Sartori E; Doignon JL; Grognet JM
Xenobiotica; 1989 Nov; 19(11):1285-95. PubMed ID: 2618081
[TBL] [Abstract][Full Text] [Related]
52. pH effects on the N-demethylation and formation of the cytochrome P-450 iron II nitrosoalkane complex for erythromycin derivatives.
Delaforge M; Ladam P; Bouillé G; Benarous JG; Jaouen M; Girault JP
Chem Biol Interact; 1992 Dec; 85(2-3):215-27. PubMed ID: 1493610
[TBL] [Abstract][Full Text] [Related]
53. The cytochrome P-450 metabolite complex derived from troleandomycin: properties in vitro and stability in vivo.
Delaforge M; Jaouen M; Mansuy D
Chem Biol Interact; 1984 Oct; 51(3):371-6. PubMed ID: 6333292
[No Abstract] [Full Text] [Related]
54. Formation of an inactive cytochrome P-450Fe(II)-metabolite complex after administration of amiodarone in rats, mice and hamsters.
Larrey D; Tinel M; Letteron P; Geneve J; Descatoire V; Pessayre D
Biochem Pharmacol; 1986 Jul; 35(13):2213-20. PubMed ID: 3729976
[TBL] [Abstract][Full Text] [Related]
55. Macrolide antibacterials. Drug interactions of clinical significance.
von Rosensteil NA; Adam D
Drug Saf; 1995 Aug; 13(2):105-22. PubMed ID: 7576262
[TBL] [Abstract][Full Text] [Related]
56. Effects of roxithromycin, a new semisynthetic macrolide, and two erythromycins on drug metabolizing enzymes in rat liver.
Villa P; Sassella D; Corada M; Bartosek I
J Antibiot (Tokyo); 1988 Apr; 41(4):563-9. PubMed ID: 3372362
[TBL] [Abstract][Full Text] [Related]
57. Effects of troleandomycin and josamycin on thyroid hormone and steroid serum levels, liver function tests and microsomal monooxygenases in healthy volunteers: a double blind placebo-controlled study.
Uzzan B; Nicolas P; Perret G; Vassy R; Tod M; Petitjean O
Fundam Clin Pharmacol; 1991; 5(6):513-26. PubMed ID: 1955196
[TBL] [Abstract][Full Text] [Related]
58. Uptake of clarithromycin by rat lung cells.
Kohno Y; Yoshida H; Suwa T; Suga T
J Antimicrob Chemother; 1990 Oct; 26(4):503-13. PubMed ID: 2147673
[TBL] [Abstract][Full Text] [Related]
59. The pharmacological and pharmacokinetic properties of troleandomycin.
Genazzani E
Quad Antibiot; 1975 Jun; ():35-56. PubMed ID: 210708
[No Abstract] [Full Text] [Related]
60. Effects of macrolide antibiotics on barbiturate sleeping time in mice.
Descotes J; Evreux JC
Experientia; 1983 Dec; 39(12):1389-90. PubMed ID: 6606586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
